0
Your cart

Your cart is empty

Books > Medicine > Other branches of medicine > Pharmacology

Buy Now

Antifolate Drugs in Cancer Therapy (Hardcover, 1999 ed.) Loot Price: R5,550
Discovery Miles 55 500
Antifolate Drugs in Cancer Therapy (Hardcover, 1999 ed.): Ann L. Jackman

Antifolate Drugs in Cancer Therapy (Hardcover, 1999 ed.)

Ann L. Jackman

Series: Cancer Drug Discovery and Development

 (sign in to rate)
Loot Price R5,550 Discovery Miles 55 500 | Repayment Terms: R520 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Antifolates are an important class of anticancer drugs originally developed as anti leu- kemic agents, but now used, usually in combination with other drugs, for the treatment of a wide range of tumors, notably carcinomas of the head and neck, breast, germ cell tumors, non-Hodgkin's lymphoma, acute lymphoblastic leukemia, and osteogenic sar- comas. 5-Fluorouracil and its prodrugs also target, in part, the folate-dependent enzyme, thymidylate synthase. Furthermore, folate supplementation in the form of leucovorin, modulates 5-fluororuacil activity. 5-Fluorouracil is widely used in the treatment of colorectal and gastric cancer and in combination for other solid tumors such as breast and head and neck cancers. Ongoing clinical trials with the newer antifolates suggest that the range of solid tumors where these agents will be of use may broaden further. Half a century ago, interesting scientific and clinical discoveries suggested that folie acid was a vitamin involved in vital cellular metabolic processes. The folate analogs, aminopterin and methotrexate, were synthesized by the American Cyanamid Company in an attempt to interfere with these processes and were shown to have anticancer activity by Farber and his colleagues. Hence, the principle of antimetabolite therapy for the treatment of cancer was established. Biomedical research over the following years led to a deeper understanding of the complex biochemical pharmacology of folates and antifolates. Selective antimicrobial agents were discovered, but more tumor-selective anticancer agents did not immediately emerge.

General

Imprint: HumanaPress
Country of origin: United States
Series: Cancer Drug Discovery and Development
Release date: 1999
First published: 1999
Editors: Ann L. Jackman
Dimensions: 254 x 178 x 25mm (L x W x T)
Format: Hardcover
Pages: 456
Edition: 1999 ed.
ISBN-13: 978-0-89603-596-6
Categories: Books > Medicine > Other branches of medicine > Pharmacology > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > Chemotherapy
LSN: 0-89603-596-4
Barcode: 9780896035966

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners